机器人辅助根治性前列腺切除术中减少术后早期导管相关膀胱不适的术中策略
这项前瞻性队列分析纳入391例接受机器人辅助根治性前列腺切除术的前列腺癌患者,比较8种术中麻醉方案对术后早期导管相关膀胱不适的影响。结果显示,腹横肌平面阻滞联合罗哌卡因膀胱周围及尿道周围浸润的方案导管相关膀胱不适发生率最低(36% vs 基线70%,p=0.001),接受局部浸润者发生率显著低于未接受者(46.5% vs 60.7%,p=0.001)。
要点
- 罗哌卡因膀胱周围及尿道周围浸润可降低术后早期导管相关膀胱不适发生率。
- 联合方案(腹横肌平面阻滞+膀胱周围+尿道周围浸润)发生率36%,显著低于基线70%。
- 接受局部浸润者导管相关膀胱不适发生率46.5%,低于未接受者的60.7%。
核心结论
- 罗哌卡因膀胱周围及尿道周围注射可将术后早期导管相关膀胱不适发生率降低达49%。
- 需进一步随机研究确定预防术后早期导管相关膀胱不适的最佳方案。
研究设计与样本
- 前瞻性队列分析,纳入2017年1月至2020年4月单中心391例活检证实前列腺癌并接受机器人辅助根治性前列腺切除术的患者。
- 比较8种术中治疗方案,包括全身麻醉联合腹横肌平面阻滞,分别加可乐定、氯胺酮、罗哌卡因膀胱周围浸润、罗哌卡因尿道周围浸润或罗哌卡因阴茎背神经阻滞。
- 采用多因素logistic回归和线性混合模型分析术后恢复室导管相关膀胱不适及疼痛(0-10分)差异。
主要发现
- 腹横肌平面阻滞联合罗哌卡因膀胱周围及尿道周围阻滞者导管相关膀胱不适发生率最低,为36%,基线方案(仅腹横肌平面阻滞)为70%,p=0.001。
- 接受尿道周围和/或膀胱周围浸润者导管相关膀胱不适发生率为46.5%,未接受者为60.7%,p=0.001。
关键数值与推荐
- 基线方案为腹横肌平面阻滞,其导管相关膀胱不适发生率为70%。
- 联合罗哌卡因膀胱周围及尿道周围浸润方案的发生率为36%,与基线比较p=0.001。
- 局部浸润亚组分析显示发生率46.5% vs 60.7%,p=0.001。
临床怎么用
- 对于接受机器人辅助根治性前列腺切除术的患者,可考虑在腹横肌平面阻滞基础上加用罗哌卡因膀胱周围及尿道周围浸润以减轻术后早期导管相关膀胱不适。
- 该策略仍需随机对照研究验证后方可作为标准方案推广。
局限性
- 本研究为前瞻性队列分析,非随机对照设计可能存在混杂偏倚。
- 原文未报告随机化及盲法信息。
- 结论需进一步随机研究确认最佳治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Catheter-related bladder discomfort occurs in up to 63% of patients following robot-assisted radical prostatectomy. The optimal intraoperative anesthesia regime to prevent patients from catheter-related bladder discomfort is unknown. MATERIALS AND METHODS: A prospective cohort analysis was conducted. Patients with biopsy-proven prostate cancer selected for robot-assisted radical prostatectomy were included between January 2017 and April 2020 from a high volume prostate cancer center. Eight different treatment regimens were compared, ie a combination of general anesthesia and a transversus abdominis plane block with either an additional dose of clonidine or an additional dose of ketamine, or perivesical infiltrations (with 20 ml ropivacaine), or periurethral infiltrations (with ropivacaine); or a dorsal penile nerve block (with 20 ml ropivacaine). Multiple logistic regression and linear mixed models were used to analyze differences in catheter-related bladder discomfort and pain (0-10) at the postoperative recovery unit between the treatment protocols. RESULTS: Of the 391 patients included, those with a combination transversus abdominis plane block, perivesical and periurethral block with ropivacaine had the lowest incidence of catheter-related bladder discomfort, clinically relevant and statistically significantly lower compared to our baseline protocol (transversus abdominis plane block only), ie 36% vs 70%, p=0.001. Overall, patients who were treated with periurethral and/or perivesical infiltrations reported a statistically significantly lower incidence of catheter-related bladder discomfort compared to patients who did not receive this local infiltration (46.5% vs 60.7%, p=0.001). CONCLUSIONS: Perivesical and periurethral injections with ropivacaine have the potential to reduce the incidence of early postoperative catheter-related bladder discomfort by up to 49%. Further randomized studies are necessary to determine the optimal treatment regime to prevent early postoperative catheter-related bladder discomfort.
引用
- Veerman H, Houwink API, Schutte PFE, et al. Intraoperative Strategies to Reduce Catheter-Related Bladder Discomfort in the Early Postoperative Period after Robot-Assisted Radical Prostatectomy. J Urol. 2021. PMID: 33605794. doi:10.1097/JU.0000000000001645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。